Vext Science, Inc. ( VEXTF) - Stock Earnings
VEXTF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -927260 USD | 11.6 million USD |
| 2025Q2 | -2.7 million USD | 13.4 million USD |
| 2025Q3 | -2.8 million USD | 12.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VEXTF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 8.9 million USD | 35.4 million USD |
| 2023 | -10.5 million USD | 34.8 million USD |
| 2024 | -15.5 million USD | 36.0 million USD |
| 2026 Est. | — | — |
VEXTF
Price: $0.18
52 week price:
Earnings Per Share: -0.07 USD
P/E Ratio: -2.57
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 37.7 million